LBSP Favicon

Toxys reports positive results from the OECD ring trial validation

On April 9th 2024, Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©.

ToxTracker is an in vitro method that accurately predicts genotoxicity without the use of animals. The results constitute an essential part of the approval process by the OECD for international acceptance of novel methods by regulatory authorities.

The evaluation was finalized earlier in the year and data have been submitted to the OECD showing that ToxTracker consistently demonstrates high accuracy and excellent reproducibility of test results, both within and between different laboratories. These data prove that ToxTracker is both robust and reliable. Importantly, ToxTracker can provide insight into the mode of action of genotoxic compounds thereby significantly improving the in vitro safety assessment of novel pharmaceutical products, chemicals, cosmetics and food-related products.

Visit the page below for the full press release and a link to the publication:

Toxys publication on OECD ring trial validation of ToxTracker

Related posts

Join BIO KOREA 2025

Join BIO KOREA 2025

From 6–9 May 2025, the Netherlands Embassy in Seoul, in collaboration with the Netherlands Enterprise Agency (RVO), is organising a trade mission to South Korea focused on the...

HLTH Europe 2025

HLTH Europe 2025

Secure Your Spot in the Dutch Innovator Village at HLTH Europe 2025! Are you ready to present your health tech innovation to the world at HLTH Europe in RAI Amsterdam? Spaces are...